213 related articles for article (PubMed ID: 12411093)
21. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
van Riel PL; van Gestel AM; van de Putte LB
Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
[TBL] [Abstract][Full Text] [Related]
22. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
[TBL] [Abstract][Full Text] [Related]
23. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
Wolfe F; Michaud K; Stephenson B; Doyle J
J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927
[TBL] [Abstract][Full Text] [Related]
24. Drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
[No Abstract] [Full Text] [Related]
25. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
26. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Agarwal S; Zaman T; Handa R
Singapore Med J; 2009 Jul; 50(7):686-92. PubMed ID: 19644623
[TBL] [Abstract][Full Text] [Related]
27. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
Wolfe F; Hawley DJ; Cathey MA
J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of methotrexate induced nodulosis with D-penicillamine.
Dash S; Seibold JR; Tiku ML
J Rheumatol; 1999 Jun; 26(6):1396-9. PubMed ID: 10381063
[TBL] [Abstract][Full Text] [Related]
29. Disease modifying antirheumatic drugs: longterm safety issues.
Capell HA
J Rheumatol Suppl; 2001 Jun; 62():10-5. PubMed ID: 11409152
[TBL] [Abstract][Full Text] [Related]
30. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
Conaghan PG; Brooks P
Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
[TBL] [Abstract][Full Text] [Related]
31. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
Husain Z; Runge LA
J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692
[TBL] [Abstract][Full Text] [Related]
32. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
Clegg DO; Ward JR
Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs.
Schipper LG; Fransen J; Barrera P; Van Riel PL
Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163
[TBL] [Abstract][Full Text] [Related]
34. Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.
Bonafede M; Johnson BH; Tang DH; Shah N; Harrison DJ; Collier DH
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1656-63. PubMed ID: 26097194
[TBL] [Abstract][Full Text] [Related]
35. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
36. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.
Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF
Arthritis Rheum; 2008 Jul; 59(7):905-10. PubMed ID: 18576295
[TBL] [Abstract][Full Text] [Related]
37. Infliximab therapy in established rheumatoid arthritis: an observational study.
Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
[TBL] [Abstract][Full Text] [Related]
38. Changing patterns in the use of slow acting antirheumatic drugs for the treatment of rheumatoid arthritis.
Horsfall MW; Shaw JP; Highton J; Cranch PJ
N Z Med J; 1998 Jun; 111(1067):200-3. PubMed ID: 9673632
[TBL] [Abstract][Full Text] [Related]
39. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
Tao X; Cush JJ; Garret M; Lipsky PE
J Rheumatol; 2001 Oct; 28(10):2160-7. PubMed ID: 11669150
[TBL] [Abstract][Full Text] [Related]
40. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.
Lu LJ; Bao CD; Dai M; Teng JL; Fan W; Du F; Yang NP; Zhao YH; Chen ZW; Xu JH; He PG; Wu HX; Tao Y; Zhang MJ; Han XH; Li XF; Gu JR; Li JH; Yu H
Arthritis Rheum; 2009 Jul; 61(7):979-87. PubMed ID: 19565542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
